Fiche du document
2013
- doi: 10.1016/j.virol.2013.03.021
- issn: 0042-6822
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.virol.2013.03.021
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/23601783
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1096-0341
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E3A8998CC6155
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Populations, Human Human populations Population growth Human populationCiter ce document
N. Rahm et al., « Susceptibility and adaptation to human TRIM5α alleles at positive selected sites in HIV-1 capsid. », Serveur académique Lausannois, ID : 10.1016/j.virol.2013.03.021
Métriques
Partage / Export
Résumé
Numerous in vitro studies attribute to human TRIM5α some modest anti-HIV-1 activity and human population studies suggest some differential effect of TRIM5α polymorphisms on disease progression. If the activity of TRIM5α were relevant in vivo, it could result in positive selection on the viral capsid. To address this issue, we identified 10 positively selected sites in HIV-1 capsid from multiple viral strains and generated 17 clade B viruses carrying a minor (i.e. low frequency) residue or an alanine at those positions. All recombinant viruses were susceptible to the modest effect of common human TRIM5α and allelic variants R136Q, and H419Y; H43Y and G249D TRIM5α were generally inactive. Increased sensitivity to TRIM5α was observed for some capsid variants, suggesting that minor residues are selected against in human populations. On the other hand, the modest potency of human TRIM5α does not translate in escape mutations in the viral capsid.